Cambridge Healthtech Institute & Bio-IT World Announces Program for Its 13th Ann ual Structure-Based Drug

Design Conference Featuring Keynote from Aileron Therapeutics Tomi Sawyer. Needham, MA, March 05, 2013 -- Cambridge Healthtech Institute (CHI) & Bio-IT Wor ld released today the complete agenda for the 13th annual Structure-Based Drug D esign conference taking place June 19-21, 2013 at the Revere Hotel in Boston, MA . The meeting serves as the original conference for the structure-based design commu nity for industry and academic practitioners where delegates will learn about de velopments in in silico technology, as well as experimental approaches useful fo r accurately predicting and modeling the structures of proteins in structure-bas ed drug design efforts. Examples of successful applications of such technology a pproaches to genome-to-drug lead investigations will also be discussed. I look forward to a great event this year," notes CHI Conference Director, Ming G uo. I am inspired by the ambitious work from researchers in the SBDD field. CHI & Bio-IT World is honored the industry turns to us every year to organize this co nference. This event boasts an impressive line-up of leading industry experts including a keynote presentation by Tomi Sawyer, Ph.D., CSO, SVP, Discovery & Innovative Tec hnologies, Aileron Therapeutics. Dr. Sawyers presentation, entitled Drugging the U ndruggable: Transforming Nature s -Helix into Breakthrough Medicines, will take pl ace on Thursday, June 20. As a case study, advancements in stapled peptide techn ology to transform Natures -helix into breakthrough medicines will be presented. The International Society for Computational Biology (ISCB) has endorsed its supp ort as a sponsoring society. Due to the overwhelmingly popularity of the Structu re-Based Drug Design event, CHI will once again co-locate its Next-Gen Kinase In hibitors conference to run June 17-19. This gives delegates the unique opportuni ty to connect with the kinase community and attend the Structure-Based Drug Desi gn event by obtaining an all access, discounted pass. Early registration discounts will be offered until March 22, 2013. For more deta ils, visit healthtech.com/sbd. To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com. Writers and editors are invited to attend. To request a press pass, contact Lisa Scimemi at tfielding@healthtech.com. About Cambridge Healthtech Institute (chicorporate.com) Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and ac ademic organizations. CHIs portfolio of products includes Cambridge Healthtech In stitute Conferences, Insight Pharma Reports, Barnett International, Cambridge Ma rketing Consultants, Cambridge Meeting Planners and Cambridge Healthtechs Media G roup, which includes numerous e-newsletters as well as Bio-IT World magazine. Founded in 1992, Cambridge Healthtech Institute strives to develop quality infor mation sources that provide valuable new insights and competing points of view w hile offering balanced coverage of the latest developments. Basic research relat ed to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy b ehind the business.

About Bio-IT World: (www.bio-itworld.com) Part of the Cambridge Healthtech Institute Media Group (chimediagroup.com), BioIT World provides outstanding coverage of cutting-edge trends and technologies t hat impact the management and analysis of life sciences data, including next-gen eration sequencing, drug discovery, predictive and systems biology, informatics tools, clinical trials, and personalized medicine. Through a variety of sources including, www.Bio-ITWorld.com, Weekly Update Newsletter and the Bio-IT World Ne ws Bulletins, Bio-IT World is a leading source of news and opinion on technology and strategic innovation in the life sciences, including drug discovery, develo pment. Contact: James Prudhomme Cambridge Healthtech Institute 250 First Avenue, Suite 300 Needham, MA 02494 781-972-5400 jprudhomme@healthtech.com http://www.chicorporate.com